Self-adjuvanting influenza candidate vaccine presenting epitopes for cell-mediated immunity on a proteinaceous multivalent nanoplatform.
Vaccine
; 31(40): 4338-46, 2013 Sep 13.
Article
em En
| MEDLINE
| ID: mdl-23880363
Palavras-chave
APC; Ad; Ad3; Adenoviral dodecahedron; CTL; Cell-mediated immunity; Dd; FCS; HA; HLA; Influenza vaccine; M1 immunodominant epitopes; MoDC; NA; PBMC; PE; PMA/Iono; Pb; SPF; VLP; Virus-like particle; aa; adenovirus; adenovirus serotype 3; amino acid; antigen-presenting cells; cytotoxic T lymphocyte; dodecahedron; fetal calf serum; hemagglutinin; human leukocyte antigen (a group of the most important antigens responsible for tissue compatibility); monocyte-derived dendritic cells; neuraminidase; pDC; penton base protein; peripheral blood mononuclear cells; phorbol 12-myristate 13-acetate/ionomycin; phycoerythrin; plasmacytoid dendritic cells; recombinant wild-type Dd; rwtDd; specific pathogen-free; virus-like particle
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Vacinas contra Influenza
/
Linfócitos T CD4-Positivos
/
Proteínas da Matriz Viral
/
Linfócitos T CD8-Positivos
/
Epitopos
Limite:
Animals
/
Humans
Idioma:
En
Revista:
Vaccine
Ano de publicação:
2013
Tipo de documento:
Article
País de afiliação:
Polônia